Table 1.

Demographic and clinical characteristics of patients in this cohort

Overall (n = 89) Lacking CHD1 IHC n = 6 (6.7%)CHD1 negative in CRPC n = 13 (14.6%)CHD1 positive in CRPC n = 70 (78.7%)P
Age at diagnosis, years (mean, SD)62.7 (6.8)59.9 (13.1)P = 0.46a
Gleason at diagnosis
 62 (15%)5 (7%)P = 0.71b
 72 (15%)16 (23%)
 8–108 (62%)44 (63%)
 NA1 (8%)5 (7%)
Metastasis at diagnosis
 M05 (39%)43 (61%)P = 0.14b
 M18 (62%)27 (39%)
PSA at diagnosis, ln (μg/L; mean, SD)4.8 (1.6)5 (1.6)P = 0.82a
Treatments for CRPC
 Docetaxel11 (85%)64 (93%)P = 0.31b
 Abiraterone9 (69%)62 (90%)P = 0.07b
  • at test.

  • bFisher exact test.